October 2009 ASCO's Diversity in Oncology Initiative - Building a multicultural workforce Look inside: Select One

Spotlight ASCO Rings the NYSE Bell On August 19, The ASCO Cancer Foundation® and ASCO joined the ranks of the many notable businesses, organizations, and celebrities that have rung the New York Stock Exchange's Closing Bell.® ASCO Continues Successful Leadership Development Program The Leadership Development Program provides participants with extensive exposure to the roles and mission of ASCO and the Society's powerful place in developing the future of cancer care. QOPI® Certification Program Promotes Excellence in Cancer Care ASCO has launched the Quality Oncology Practice Initiative (QOPI®) Certification Program to recognize oncology practices that achieve rigorous standards for high-quality cancer care. Current Controversies in Oncology The Controversey: CT Colonography for Colorectal Cancer Screening vs. Optical Colonoscopy Abraham H. Dachman, MD, Hemant K. Roy, MD, and Michael J. Goldberg, MD, debate the use of optical colonoscopy versus CT colonography to detect precancerous and cancerous polyps. ASCO News & Forum wants to hear from you.

Online Exclusives

NCI Program Highlights - Putting Minds and Words Together: The NCI, C-Change Cooperative Effort in Communication: C-Change, including NCI, ASCO, and other national cancer leaders, has worked to unite the entire cancer community around a core set of consumer-tested messages related to reducing people’s risk for cancer.

Family of Websites - ASCO University™ Provides Interactive, Social Learning for Oncology Professionals: Jamie Von Roenn, MD, discusses how ASCO University™ provides users with a diverse collection of content and supporting resources.

Tribute - ASCO Remembers William A. Knight III, MD : William A. Knight III, MD, a respected cancer researcher and dedicated practicing oncologist, died on May 16, 2009.

Spotlight on State Affiliates - West Virginia Oncology Society: John Azar, MD, discusses the activities of the West Virginia Oncology Society.

Clinical Practice Guidelines - Breast Cancer Risk Reduction Guideline Update: The Journal of Clinical Oncology (JCO) recently published ASCO’s Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction.